Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent
Top Cited Papers
- 17 February 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (6), 701-705
- https://doi.org/10.1161/01.cir.0000116202.41966.d4
Abstract
Background— The US Food and Drug Administration recently issued a warning of subacute thrombosis and hypersensitivity reactions to sirolimus-eluting stents (Cypher). The cause and incidence of these events have not been determined.Keywords
This publication has 23 references indexed in Scilit:
- Long-Term Follow-Up of Incomplete Stent Apposition in Patients Who Received Sirolimus-Eluting Stent for De Novo Coronary LesionsCirculation, 2003
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Regional Remodeling as the Cause of Late Stent MalappositionCirculation, 2003
- New Frontiers in CardiologyCirculation, 2003
- New Frontiers in CardiologyCirculation, 2003
- Pilot Trial of Oral Rapamycin for Recalcitrant RestenosisCirculation, 2003
- Sirolimus-induced leukocytoclastic vasculitisTransplantation, 2002
- Granulomatous ‘foreign body reactions’ contribute to exaggerated in-stent restenosisCoronary Artery Disease, 1999
- Coronary stent coatingsCoronary Artery Disease, 1994
- Rapamycin inhibits airway leukocyte infiltration and hyperreactivity in guinea pigsInflammation Research, 1993